Stay updated on Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial

Sign up to get notified when there's something new on the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A banner was added announcing the NIH website transition and explaining that some content may use “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    0.7%
    Check dated 2026-10-24T12:41:29.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The site footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T13:11:04.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.1 instead of v3.7.0.
    Difference
    0.1%
    Check dated 2026-10-10T13:45:35.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    A new revision entry (v3.7.0) was added to the study's record history, and the previous revision (v3.6.6) was removed, signaling an updated submission to the record.
    Difference
    0.1%
    Check dated 2026-09-19T19:01:43.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    No additions or deletions are reported for this page.
    Difference
    0.1%
    Check dated 2026-09-05T20:04:53.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the study record history, superseding the previous v3.6.5. This appears to be an administrative/quality-control update to the record rather than a change to study data or public content.
    Difference
    0.1%
    Check dated 2026-08-29T20:59:54.000Z thumbnail image

Stay in the know with updates to Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Study of DPX-Survivac Combo with Pembrolizumab in Clinical Trial page.